Biotech

All Articles

ArsenalBio increases $325M, rotates off of past lead asset

.Arsenal Biosciences is actually going on up. The tissue therapy firm has actually added on $325 tho...

Lilly- supported fat loss biotech files IPO

.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has actually s...

Aelis' cannabis usage drug fails period 2b, steering Indivior to review $100M option

.Aelis Farma's chances of getting a quick, positive selection on a $one hundred million possibility ...

ProKidney stops phase 3 test certainly not needed to have for tissue treatment permission

.ProKidney has actually stopped some of a pair of phase 3 tests for its own tissue treatment for ren...

Vaxcyte surges on 'sensational' 31-valent PCV gain against Pfizer

.Vaxcyte unveiled what professionals named "stunning" phase 1/2 records for its own 31-valent pneumo...

Recursion's human brain ailment trial shows insufficient evidence of effectiveness

.Recursion has actually discovered by means of an early test of its tech-enabled strategy to medicin...

Acepodia, Pfizer click on all together for chemistry-based cell therapy

.Call it a case of excellent chemical make up: Acepodia, a biotech based on Nobel Champion scientifi...

Praxis epilepsy medicine reduces seizures in period 2 trial

.Practice Preciseness Medicines has actually racked up another midphase win in epilepsy this year, w...

Three officers resign as Dyne articles blended data for DMD applicant

.After escaping a professional grip a number of years back, Dyne Therapy has shown new period 1/2 re...

Arrowhead fires off period 3 records in rare metabolic ailment in advance of market encounter Ionis

.Arrowhead Pharmaceuticals has actually presented its give ahead of a potential face-off with Ionis,...